Joe Bonaccorso
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joe Bonaccorso
Verrica Pharmaceuticals Inc. reported in an 8-K filed August 27, 2024 that Joe Bonaccorso resigned as Chief Commercial Officer, effective August 30, 2024. The proxy statement of Verrica Pharmaceuticals Inc. reports total compensation of $1,279,038 for Joe Bonaccorso in fiscal 2024, including a base salary of $307,840. Disclosed compensation is on record for 4 fiscal years.
“On August 21, 2024, Mr. Bonaccorso notified Verrica Pharmaceuticals Inc. (the "Company") that he will resign from his position as Chief Commercial Officer of the Company, effective August 30, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Verrica Pharmaceuticals Inc. (VRCA)
Proxy statement
Start not stated–2024-08-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Verrica Pharmaceuticals Inc. (VRCA) | Former Chief Commercial Officer | $307,840 | $1,279,038 |
| 2023 | Verrica Pharmaceuticals Inc. (VRCA) | Former Chief Commercial Officer | $444,000 | $2,097,472 |
| 2022 | Verrica Pharmaceuticals Inc. (VRCA) | Chief Commercial Officer | $425,000 | $986,518 |
| 2021 | Verrica Pharmaceuticals Inc. (VRCA) | Chief Commercial Officer | $408,825 | $1,224,333 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.